Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siyu Lou

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 7, 2026
Unsupervised Hierarchical Symbolic Regression for Interpretable Property Modeling in Complex Multi-Variable SystemsSiyu Lou, Chengchun Liu, Dongxiao Zhang, et al.
Frontiers in Pharmacology|May 13, 2025
Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databasesTao Wang, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology|June 24, 2025
Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024Siyu Lou, Huayou Chen, Zhiwei Cui, et al.
Frontiers in Pharmacology|January 8, 2024
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) databaseFan Zou, Chengyu Zhu, Siyu Lou, et al.
Frontiers in Pharmacology|November 21, 2024
Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroupsYingyong Ou, Zhiwei Cui, Siyu Lou, et al.
Frontiers in Pharmacology|March 27, 2025
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting systemChengyu Zhu, Zhiwei Cui, Tingting Liu, et al.
BMC Psychiatry|January 20, 2025
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databasesSiyu Lou, Zhiwei Cui, Yingyong Ou, et al.
Acta Biomaterialia|August 22, 2016
Micropore-induced capillarity enhances bone distribution in vivo in biphasic calcium phosphate scaffoldsLaurence E Rustom, Thomas Boudou, Siyu Lou, et al.
Annals of the New York Academy of Sciences|July 22, 2025
Audio multi-feature fusion detection for depression based on graph convolutional networksGuangsheng Luo, Xianda Ma, Jun Yea, et al.
Frontiers in Pharmacology|February 15, 2024
From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysisZhiwei Cui, Zhen Zhai, De Xie, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 7, 2026
Unsupervised Hierarchical Symbolic Regression for Interpretable Property Modeling in Complex Multi-Variable SystemsSiyu Lou, Chengchun Liu, Dongxiao Zhang, et al.
Frontiers in Pharmacology|May 13, 2025
Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databasesTao Wang, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology|June 24, 2025
Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024Siyu Lou, Huayou Chen, Zhiwei Cui, et al.
Frontiers in Pharmacology|January 8, 2024
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) databaseFan Zou, Chengyu Zhu, Siyu Lou, et al.
Frontiers in Pharmacology|November 21, 2024
Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroupsYingyong Ou, Zhiwei Cui, Siyu Lou, et al.
Frontiers in Pharmacology|March 27, 2025
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting systemChengyu Zhu, Zhiwei Cui, Tingting Liu, et al.
BMC Psychiatry|January 20, 2025
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databasesSiyu Lou, Zhiwei Cui, Yingyong Ou, et al.
Acta Biomaterialia|August 22, 2016
Micropore-induced capillarity enhances bone distribution in vivo in biphasic calcium phosphate scaffoldsLaurence E Rustom, Thomas Boudou, Siyu Lou, et al.
Annals of the New York Academy of Sciences|July 22, 2025
Audio multi-feature fusion detection for depression based on graph convolutional networksGuangsheng Luo, Xianda Ma, Jun Yea, et al.
Frontiers in Pharmacology|February 15, 2024
From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysisZhiwei Cui, Zhen Zhai, De Xie, et al.
Pageof 2